Update οn the diagnosis and management of systemic lupus erythematosus.
Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT.
Ann Rheum Dis. 2021 Jan;80(1):14-25. doi: 10.1136/annrheumdis-2020-218272. Epub 2020 Oct 13.
Calcineurin inhibitor nephrotoxicity.
Naesens M, Kuypers DR, Sarwal M.
Clin J Am Soc Nephrol. 2009 Feb;4(2):481-508. doi: 10.2215/CJN.04800908.
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.
Rovin BH, Teng YKO, Ginzler EM, Arriens C, Caster DJ, Romero-Diaz J, Gibson K, Kaplan J, Lisk L, Navarra S, Parikh SV, Randhawa S, Solomons N, Huizinga RB.
Lancet. 2021 May 29;397(10289):2070-2080. doi: 10.1016/S0140-6736(21)00578-X. Epub 2021 May 7.
Childhood nephrotic syndrome.
Vivarelli M, Gibson K, Sinha A, Boyer O.
Lancet. 2023 Sep 2;402(10404):809-824. doi: 10.1016/S0140-6736(23)01051-6.
Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis.
Barrera-Chimal J, Girerd S, Jaisser F.
Kidney Int. 2019 Aug;96(2):302-319. doi: 10.1016/j.kint.2019.02.030. Epub 2019 Mar 13.
Chronic Kidney Disease After Liver Transplantation.
Cabeza Rivera FH, Concepcion BP, Levea SL.
Adv Kidney Dis Health. 2023 Jul;30(4):368-377. doi: 10.1053/j.akdh.2023.07.004.
Exploratory calcineurin inhibitor-free regimens in living-related kidney transplant recipients.
Garcia R, Machado PG, Felipe CR, Park SI, Spinelli GA, Franco MF, Tedesco-Silva H Jr, Medina-Pestana JO.
Braz J Med Biol Res. 2007 Apr;40(4):457-65. doi: 10.1590/s0100-879x2007000400003.
Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients.
Karpe KM, Talaulikar GS, Walters GD.
Cochrane Database Syst Rev. 2017 Jul 21;7(7):CD006750. doi: 10.1002/14651858.CD006750.pub2.
A broad clinical spectrum of PLCepsilon1-related kidney disease and intrafamilial variability.
Yılmaz EK, Saygili S, Gulhan B, Canpolat N, Bayazıt AK, Kilic BD, Akıncı N, Benzer M, Goknar N, Tufan AK, Kalyoncu M, Nalcacioglu H, Tekcan D, Yıldız G, Agbas A, Nayır A, Topaloglu R, Caliskan S, Ozaltin F.
Pediatr Nephrol. 2022 Aug;37(8):1855-1866. doi: 10.1007/s00467-021-05371-7. Epub 2022 Jan 16.
The pharmacogenetics of calcineurin inhibitor-related nephrotoxicity.
Hesselink DA, Bouamar R, van Gelder T.
Ther Drug Monit. 2010 Aug;32(4):387-93. doi: 10.1097/FTD.0b013e3181e44244.
